Surgical Innovations Group achieved a strong recovery in its financial performance in 2022
Surgical Innovations Group, the designer, manufacturer and distributor of technology for minimally invasive surgery, said it achieved a strong recovery in its financial performance last year and the group is well-positioned to deliver robust organic growth in 2023.
The group’s revenues increased by 24.3 per cent in 2022 to £11.34m as it achieved strong sales in the UK, Japan and key EU markets.
The chairman of Surgical Innovations, Nigel Rogers said: " New geographical markets are providing some significant prospects for the forthcoming year. In India, where registration was obtained earlier this year, evaluations with key surgeons in a group of Delhi based hospitals are progressing well. A new partner in Germany has seen the conversion of a new account with further evaluations scheduled.”
"The company continues to work with key partners to strengthen the overall growth opportunities.”